Inhibition of Phosphorylation of a Forkhead Transcription Factor Sensitizes Human Ovarian Cancer Cells to Cisplatin

Emi Arimoto‐Ishida(The University of Osaka), Yuji Murata(The University of Osaka), Akiko Kimura(The University of Osaka), Keiichi Tasaka(Eunice Kennedy Shriver National Institute of Child Health and Human Development), Jun Hayakawa(The University of Osaka), Chika Ohshima(Yamagata University), Seiji Mabuchi(The University of Osaka), Kazuhiro Takahashi, Yukihiro Nishio, Hirohisa Kurachi(Osaka Women's and Children's Hospital), Toshifumi Takahashi(Fukushima Medical University), Masahide Ohmichi(Osaka University of Pharmaceutical Sciences), Masahiro Sakata(The University of Osaka)
Endocrinology
January 6, 2004
10.1210/en.2003-1199
Cited by 55

Related Papers

Estrogen Induces the Akt-dependent Activation of Endothelial Nitric-oxide Synthase in Vascular Endothelial Cells
|Journal of Biological Chemistry|2001|387
Inhibition of BAD phosphorylation either at serine 112 via extracellular signal-regulated protein kinase cascade or at serine 136 via Akt cascade sensitizes human ovarian cancer cells to cisplatin.
|PubMed|2000|249
Exosomes Promote Ovarian Cancer Cell Invasion through Transfer of CD44 to Peritoneal Mesothelial Cells
|Molecular Cancer Research|2016|232
A Physiological Role of Epidermal Growth Factor in Male Reproductive Function
|Science|1986|222
Inhibition of NFκB Increases the Efficacy of Cisplatin in in Vitro and in Vivo Ovarian Cancer Models
|Journal of Biological Chemistry|2004|212